Park Medi World Limited (NSE:PARKHOSPS)
India · Delayed Price · Currency is INR 279.30
-1.50 (-0.53%)
At close: Sep 11, 2026
Park Medi World Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 17,562 | 16,794 | 13,936 | 12,311 | 12,546 | 10,844 | |
Revenue Growth | 21.40% | 20.51% | 13.20% | -1.88% | 15.70% | 41.58% |
Cost of Revenue | 6,411 | 6,383 | 5,770 | 5,045 | 4,273 | 3,115 |
Gross Profit | 11,152 | 10,411 | 8,166 | 7,266 | 8,273 | 7,729 |
Selling, General & Admin | 2,724 | 2,773 | 2,277 | 1,649 | 1,445 | 1,274 |
Other Operating Expenses | 3,773 | 3,186 | 2,128 | 2,509 | 2,917 | 3,014 |
Operating Expenses | 7,162 | 6,584 | 4,974 | 4,664 | 4,767 | 4,639 |
Operating Income | 3,989 | 3,827 | 3,192 | 2,602 | 3,506 | 3,090 |
Interest Expense | -535.62 | -543.52 | -595.88 | -695.32 | -491.95 | -380.35 |
Interest & Investment Income | - | 291.64 | 285 | 251.01 | 157.02 | 63.32 |
Other Non Operating Income (Expenses) | 323.83 | -36.05 | -7.82 | 18.06 | -0.03 | -8.11 |
EBT Excluding Unusual Items | 3,778 | 3,539 | 2,873 | 2,176 | 3,171 | 2,765 |
Gain (Loss) on Sale of Assets | - | -0.02 | -19.43 | 14.44 | -5.96 | -2.86 |
Asset Writedown | - | - | - | -32.64 | - | - |
Other Unusual Items | - | 6.61 | 2.82 | 21.81 | -17.77 | 20.4 |
Pretax Income | 3,778 | 3,546 | 2,857 | 2,182 | 3,150 | 2,784 |
Income Tax Expense | 811.25 | 810.27 | 702.29 | 661.56 | 868.42 | 789.92 |
Earnings From Continuing Operations | 2,966 | 2,736 | 2,154 | 1,520 | 2,282 | 1,994 |
Minority Interest in Earnings | -140 | -154.37 | -138.03 | 14.85 | -85.12 | -186.07 |
Net Income | 2,826 | 2,581 | 2,016 | 1,535 | 2,197 | 1,808 |
Net Income to Common | 2,826 | 2,581 | 2,016 | 1,535 | 2,197 | 1,808 |
Net Income Growth | 34.95% | 28.01% | 31.37% | -30.13% | 21.52% | 16.78% |
Shares Outstanding (Basic) | 391 | 398 | 384 | 384 | 384 | 384 |
Shares Outstanding (Diluted) | 391 | 398 | 384 | 384 | 384 | 384 |
Shares Change | 4.69% | 3.52% | - | - | - | - |
EPS (Basic) | 7.23 | 6.49 | 5.25 | 3.99 | 5.71 | 4.70 |
EPS (Diluted) | 7.23 | 6.49 | 5.25 | 3.99 | 5.71 | 4.70 |
EPS Growth | 28.91% | 23.66% | 31.37% | -30.13% | 21.52% | 16.78% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 2,094 | 702.65 | 2,900 | 965.96 | 625.8 |
Free Cash Flow Per Share | - | 5.26 | 1.83 | 7.54 | 2.51 | 1.63 |
Gross Margin | 63.50% | 61.99% | 58.60% | 59.02% | 65.94% | 71.28% |
Operating Margin | 22.72% | 22.79% | 22.91% | 21.14% | 27.94% | 28.50% |
Profit Margin | 16.09% | 15.37% | 14.47% | 12.47% | 17.51% | 16.67% |
Free Cash Flow Margin | - | 12.47% | 5.04% | 23.55% | 7.70% | 5.77% |
EBITDA | 4,641 | 4,387 | 3,703 | 3,066 | 3,888 | 3,428 |
EBITDA Margin | 26.42% | 26.12% | 26.57% | 24.91% | 30.99% | 31.61% |
D&A For EBITDA | 651.35 | 559.96 | 511.06 | 464.3 | 382.25 | 338.32 |
EBIT | 3,989 | 3,827 | 3,192 | 2,602 | 3,506 | 3,090 |
EBIT Margin | 22.72% | 22.79% | 22.91% | 21.14% | 27.94% | 28.50% |
Effective Tax Rate | 21.48% | 22.85% | 24.58% | 30.32% | 27.57% | 28.38% |
Revenue as Reported | 17,886 | 17,110 | 14,260 | 12,631 | 12,722 | 10,940 |
Advertising Expenses | - | 159.42 | 168.72 | 66.41 | 78.9 | 61.11 |